Comparative pharmacokinetics of oral 6-mercaptopurine and intravenous 6-mercaptopurine riboside in children

Pediatrics International

Volumn 43, Issue 6, 2001, Pages 673-677

  Mawatari, Hideo ^a   Unei, Kazuhiko ^a   Nishimura, Shin Ichiro ^a   Sakura, Nobuo ^a   Ueda, Kazuhiro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

6 mercaptopurine; 6 mercaptopurine riboside; 6 thioguanine nucleotides

Indexed keywords

HEMOGLOBIN; MERCAPTOPURINE; MERCAPTOPURINE RIBOSIDE; NUCLEOTIDE; TIOGUANINE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL; TIME;

6-MERCAPTOPURINE; ADMINISTRATION, ORAL; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA; MALE; THIOINOSINE;

EID: 0035166022     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2001.01475.x     Document Type: Article

References (20)

1. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia
2. Thiopurine methyltransferase biochemical genetics: Human lymphocyte activity
3. Compliance of pediatric and adolescent cancer patients
4. A reliable method for evaluating drug compliance in children with cancer
5. Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol
6. Variable bioavailability of oral mercaptopurine: Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?
7. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia
8. Digestion and absorption of bovine milk xanthine oxidase and its role as an aldehyde oxidase
9. Reversed-phase high-performance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample
10. Intravenous mercaptopurine: Life begins at 40
11. Comparative clinical toxicity of 6-mercaptopurine (NSC-755) and 6-mercaptopurine ribonucleoside (NSC-4911) administered intravenously to patients with advanced cancer
12. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine
13. 6-Mercaptopurine in cerebrospinal fluid during oral maintenance therapy of children with acute lymphoblastic leukemia
14. Central nervous system leukemia
15. Intrathecal 6-mercaptopurine, preclinical pharmacology, phase I/II trial, and pharmacokinetic study
16. Pharmacokinetics and distribution of 6-mercaptopurie administered intravenously in children with lymphoblastic leukaemia
17. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia
18. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A pediatric oncology group study
19. Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion
20. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia